Share your opinion and gain insight from other stock traders and investors. focuses on proprietary, breaking research on promising biotech and biopharma stocks with significant potential for outsized alpha. DOW 0.03%. Presentation and panel discussion at The Alliance for Regenerative Medicine’s Cell and Gene Meeting on the Mesa, Carlsbad, CA, Oct. 2 – 4, 2019 ... About Precision BioSciences… Dedicated to improving life. Since then, WINT shares have decreased by 49.5% and is now trading at $1.87. Following the conference, a replay of the webcast will be archived for 30 days on the Precision BioSciences website. Precision BioSciences, Inc. is a life sciences company focused on utilizing its ARCUS genome editing platform to primarily treat human diseases and secondarily to provide food/agricultural solutions. This suggests a possible upside of 93.6% from the stock's current price. DTIL News: Precision BioSciences to Participate in the Jefferies Virtual Healthcare Conference. Precision's management team will host a conference call and webcast at 8:30 a.m. ... and for a discussion of ... as well as an equity investment by Lilly of $35 million in Precision's common stock. The Annual Meeting will be a completely virtual meeting, which will be conducted via live webcast. I've Joined Eli Lilly In Buying Precision BioSciences Stock. Read more from Matt Kane, CEO and co-founder of Precision BioSciences. When and where will the Annual Meeting be held? However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. Precision BioSciences Conference Call and Webcast Information. 16 Mar 2021, 04:07; Stocks News Feed. Find the latest Precision BioSciences, Inc. (DTIL) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Precision BioSciences, Inc. (DTIL) stock discussions in Yahoo Finance's forum. Precision BioSciences (DTIL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. The most advanced clinical program, CGT9486, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. Share your opinion and gain insight from other stock traders and investors. Precision BioSciences (DTIL Quick Quote DTIL - Free Report) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2020. About Cogent Biosciences, Inc. (COGT) Cogent Biosciences (COGT) is a biotechnology company focused on developing precision therapies for genetically defined diseases. ET today, Friday, November 20, 2020 to discuss the collaboration. The stock was trading 12.14% higher at $9.05 per share at the time of writing. As we navigate the unprecedented COVID-19 pandemic, we remain committed to the health and safety of our community including patients, employees, and our partners. The stock has a 52-week high of $16.60 and a 52-week low of $4.45. Overcome cancer. Their forecasts range from $14.00 to $27.00. 2- They've had positive interim results from a clinical trial that shows effectiveness of their genome editing platform in the treatment of refractory Non-Hodgkins lymphoma. DTIL News: Precision BioSciences Appoints Alex Kelly as Chief Financial Officer. Shares of Precision BioSciences (NASDAQ:DTIL) were unchanged after the company reported Q1 results.. Quarterly Results. Feed the planet. View which stocks have been most impacted by COVID-19. SCIEX Seminar Will Focus on Using Industrialized Omics to Perform Translational Research Needed to Enable Precision Medicine. 05/21/2021 12:46:42 PM. DTIL | Complete Precision Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The Annual Meeting will be held on Monday, May 10, 2021 at 11:00 a.m., Eastern Time. The Prognosis For Precision BioSciences. Precision BioSciences (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life (DTIL) through its proprietary ARCUS® genome editing platform, announced today that its Chief Scientific Officer, Derek Jantz, Ph.D., and Senior Vice President of Corporate Development, Michael Dombeck will participate in several panel discussions and presentations at … 1- A cheap genome editing stock, marketcap of just 600 mil approx. Stock Market Daily. May 24, 2021 / Travis Johnson, Stock Gumshoe Eifrig’s “#1 Biotech Stock” and Four Teased Healthcare Plays. Trending now. DTIL News: Precision BioSciences up ~7% following ASCO presentation announcement. 5 brokerages have issued twelve-month price objectives for Precision BioSciences' stock. Precision BioSciences Inc. (DTIL) stock market news,discussion, ideas from and for active investors. Precision BioSciences to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 18, 2021 - Stocks News Feed. Precision BioSciences is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARM Cell & Gene Therapies State of the Industry Briefing Date: Monday, January 13, 2020 Time: 8:00 a.m.- 9:50 a.m. PT Panel discussion: 8:20 a.m.- 9:05 a.m. PT Location: Parc 55 Hotel, San Francisco. On average, they expect Precision BioSciences' stock price to reach $20.00 in the next twelve months. Shares of Precision BioSciences ( NASDAQ:DTIL) rose as much as 19.5% today, as the company continues to benefit from its pipeline update that took place on Nov. 6. Windtree Therapeutics' stock was trading at $3.70 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). NASDAQ 1.10%. The Annual Meeting … Want the latest recommendations from Zacks Investment Research? (form 10-Q) ... references to "we," "us," "our," "the Company" and "Precision" refer to Precision BioSciences, Inc. and its subsidiaries on a consolidated basis. Business Description. Precision BioSciences takes a hit. 12 Mar 2021, 12:00; Benzinga Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. Precision BioSciences, Inc. (Exact name of registrant as specified in its charter) ... Common Stock, par value $0.000005 per share DTIL The Nasdaq Global Select Market ... Management’s Discussion and Analysis of Financial Condition and Results of Operations 99 Find the latest Precision BioSciences, Inc. (DTIL) stock discussion in Yahoo Finance's forum. You will be able to attend the Annual Meeting online and submit your questions … Precision BioSciences doesn't appear a compelling earnings-beat candidate. Today, you can download 7 Best Stocks for the Next 30 Days. Share your opinion and gain insight from other stock traders and investors. Find out if DTIL (XNAS) is the best investment for you. ————— This story was generated by … Pharmaceutical company Precision BioSciences saw its stock lose more than half its value after it released … PRECISION BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Results of Operations. Precision BioSciences CEO, Matt Kane, will also participate in a panel discussion at the Barclays Gene Editing & Gene Therapy Summit. Find the latest Precision BioSciences, Inc. (DTIL) stock discussion in Yahoo Finance's forum. Precision BioSciences doesn't appear a compelling earnings-beat candidate. Precision BioSciences shares have risen 7% since the beginning of the year. Share your opinion and gain insight from other stock traders and investors. The dial-in conference call numbers for domestic and international callers are (866) 996-7202 and (270) 215-9609, respectively. Find the latest Precision BioSciences, Inc. (DTIL) stock discussions in Yahoo Finance's forum. Precision … 05/27/2021 07:00:00 AM. (919) 314-5512 [email protected] Media Contact: Cory Tromblee Scient Public Relations 05/26/2021 07:00:00 AM. NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders of Precision BioSciences, Inc., a Delaware corporation, will be held on Monday, May 10, 2021, at 11:00 a.m., Eastern Time. Start a 14-day free trial to Morningstar Premium to unlock our take on DTIL. PRECISION BIOSCIENCES INC 11.54 0.21 (1.79%) PRECISION BIOSCIENCES INC NASDAQ Updated Jun 11, 2021 1:00 PM. Precision BioSciences doesn't appear a compelling earnings-beat candidate. Precision BioSciences, Inc. Common Stock (DTIL) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. About Precision BioSciences, Inc. Precision Bio: 2020 Is Not Looking Great With 2 Terminated Partnerships And Cash Down -30% To $127M. DTIL PRECISION BIOSCIENCES INC — Stock Price and Discussion | Stocktwits. S&P 500 0.48%. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies, today announced that the following poster, highlighting a preclinical research collaboration using its ARCUS ® genome editing platform for treatment of transthyretin amyloidosis (ATTR), will be presented at the upcoming … Share your opinion and gain insight from other stock traders and investors. Start a Discussion; Topic Archives: Precision BioSciences (DTIL) Articles. South Easton, MA, March 14, 2016 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of broadly enabling pressure cycling technology (“PCT”)-based sample preparation solutions to … Precision BioSciences doesn't appear a compelling earnings-beat candidate. The stock has increased 26% in the last 12 months. Investor Contact: Nick Riddle Precision BioSciences Tel. Find the latest Precision BioSciences, Inc. (DTIL) stock discussions in Yahoo Finance's forum. Precision BioSciences Earnings Report: Here’s what to expect from Stock market Insights & financial analysis. Get prepared with the key expectations. Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases.

Discardation Of Samples Is Done In Mcq, Grant Thornton France, Northern Lights Hotel Alaska, Covered Bridge In Winterset Iowa, Anne Arundel Diagnostics Imaging Fax Number, Does Pillars Of Eternity 1 Have Romance, Ander Herrera Trophies, Peroxychem Peracetic Acid,